What does CUSIP 91307C102 represent in this 13F holders report?

CUSIP 91307C102 is the security identifier for UTHR - UNITED THERAPEUTICS Corp - Common Stock used to aggregate holder disclosures.

How many institutions held UTHR - UNITED THERAPEUTICS Corp - Common Stock in Q2 2021?

397 institutional investors reported UTHR - UNITED THERAPEUTICS Corp - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 42,833,193
Total 13F shares: 43,453,740
Share change: +5,096
Total reported value: $7,794,694,945
Put/Call ratio: 53%
Price per share: $179.41
Number of holders: 397
Value change: +$9,014,738
Number of buys: 165
Number of sells: 193

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 91307C102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	10%	4,412,927	$738,151,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	9.6%	4,107,206	$687,013,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	7.5%	3,207,591	$536,534,000	—	31 Mar 2021	13F
Avoro Capital Advisors LLC	13F	Company	7%	3,000,000	$501,810,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	5.9%	2,525,148	$422,381,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	3.2%	1,380,087	$230,847,000	—	31 Mar 2021	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	2.4%	1,043,619	$174,564,000	—	31 Mar 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.8%	753,983	$126,114,000	—	31 Mar 2021	13F
Palo Alto Investors LP	13F	Company	1.6%	687,206	$114,949,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	1.6%	679,810	$113,712,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	1.6%	667,902	$111,719,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.6%	664,519	$111,187,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	1.5%	632,756	$105,842,000	—	31 Mar 2021	13F
FIRST TRUST ADVISORS LP	13F	Company	1.5%	632,561	$105,809,000	—	31 Mar 2021	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	1.5%	627,267	$104,923,000	—	31 Mar 2021	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	1.4%	606,793	$101,498,000	—	31 Mar 2021	13F
LSV ASSET MANAGEMENT	13F	Company	1.3%	573,396	$95,911,000	—	31 Mar 2021	13F
Consonance Capital Management LP	13F	Company	1.3%	558,162	$93,364,000	—	31 Mar 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	1.2%	504,895	$84,454,000	—	31 Mar 2021	13F
Eversept Partners, LP	13F	Company	1.1%	486,529	$81,381,706	—	31 Mar 2021	13F
NORGES BANK	13F	Company	1.1%	478,088	$79,970,000	—	31 Mar 2021	13F
Robeco Institutional Asset Management B.V.	13F	Company	1%	433,689	$72,545,000	—	31 Mar 2021	13F
Polaris Capital Management, LLC	13F	Company	0.89%	380,500	$72,249,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.99%	425,000	$71,090,000	—	31 Mar 2021	13F
Swedbank AB	13F	Company	0.96%	413,114	$69,101,579	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.94%	400,852	$67,051,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.88%	378,116	$63,247,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.87%	373,462	$62,469,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.86%	366,808	$61,356,000	—	31 Mar 2021	13F
THOMPSON SIEGEL & WALMSLEY LLC	13F	Company	0.84%	358,484	$59,963,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.83%	354,124	$59,234,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.8%	344,590	$57,640,000	—	31 Mar 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.76%	326,163	$54,404,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.75%	323,365	$54,089,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.75%	319,611	$53,461,000	—	31 Mar 2021	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	0.71%	304,323	$50,903,000	—	31 Mar 2021	13F
Marshall Wace North America L.P.	13F	Company	0.64%	272,286	$45,545,000	—	31 Mar 2021	13F
Krensavage Asset Management, LLC	13F	Company	0.58%	249,421	$41,721,000	—	31 Mar 2021	13F
Brahman Capital Corp.	13F	Company	0.58%	246,494	$41,231,000	—	31 Mar 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.55%	234,574	$39,237,000	—	31 Mar 2021	13F
ROYCE & ASSOCIATES LP	13F	Company	0.52%	223,898	$37,451,000	—	31 Mar 2021	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.52%	221,357	$37,026,000	—	31 Mar 2021	13F
Sofinnova Investments, Inc.	13F	Company	0.5%	215,054	$35,972,000	—	31 Mar 2021	13F
SCOPIA CAPITAL MANAGEMENT LP	13F	Company	0.49%	209,285	$35,007,000	—	31 Mar 2021	13F
EMERALD ADVISERS, LLC	13F	Company	0.45%	194,528	$32,539,000	—	31 Mar 2021	13F
ASSETMARK, INC	13F	Company	0.44%	190,422	$31,852,000	—	31 Mar 2021	13F
WEDGE CAPITAL MANAGEMENT L L P/NC	13F	Company	0.44%	189,626	$31,719,000	—	31 Mar 2021	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.44%	186,486	$31,194,000	—	31 Mar 2021	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.43%	182,999	$30,610,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.42%	180,226	$30,146,000	—	31 Mar 2021	13F

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2021

As of 30 Jun 2021, UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by 397 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,453,740 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Avoro Capital Advisors LLC, FMR LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, and Palo Alto Investors LP. This page lists 397 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

384

Q2 2021 holders

397

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.